𝔖 Bobbio Scriptorium
✦   LIBER   ✦

BSC1 inhibition complements effects of vasopressin V2 receptor antagonist on hyponatremia in SIADH rats

✍ Scribed by Kazama, Itsuro; Hatano, Ryo; Michimata, Mari; Suzuki, Katsuya; Arata, Tomohiro; Suzuki, Michiko; Miyama, Noriyuki; Sato, Akira; Satomi, Susumu; Ejima, Yutaka; Sasaki, Sei; Matsubara, Mitsunobu

Book ID
109067105
Publisher
Nature Publishing Group
Year
2005
Tongue
English
Weight
262 KB
Volume
67
Category
Article
ISSN
0085-2538

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effects of satavaptan, a selective vasop
Effects of satavaptan, a selective vasopressin V2 receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: A randomized trial
✍ Pere GinΓ¨s; Florence Wong; Hugh Watson; Slobodan Milutinovic; Luis Ruiz del Arbo πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 146 KB πŸ‘ 1 views

Hyponatremia in cirrhosis is associated with significant morbidity and mortality and complicates ascites management. Vasopressin receptor antagonists improve serum sodium concentration by increasing renal solute-free water excretion, but their effects on the management of ascites have not been asses